Northern Trust Corp Scynexis Inc Transaction History
Northern Trust Corp
- $761 Billion
- Q3 2025
A detailed history of Northern Trust Corp transactions in Scynexis Inc stock. As of the latest transaction made, Northern Trust Corp holds 44,948 shares of SCYX stock, worth $26,519. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,948
Previous 82,684
45.64%
Holding current value
$26,519
Previous $55,000
32.73%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding SCYX
# of Institutions
47Shares Held
12.5MCall Options Held
0Put Options Held
0-
Avidity Partners Management LP Dallas, TX3.35MShares$1.98 Million1.43% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$1.32 Million0.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$1.04 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.58MShares$934,1750.0% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC556KShares$327,7770.7% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $19.3M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...